
Please try another search
Abbisko Cayman Limited, an investment holding company, engages in the research and development of pharmaceutical products in the People’s Republic of China. The company develops Pimicotinib, which is in Phase III clinical trial for the treatment of tenosynovial giant cell tumor; Irpagratinib for the treatment of hepatocellular carcinoma; ABSK043 that is in Phase I clinical trial for the treatment of non-small cells lung cancer; and ABSK061 for the treatment of solid tumors. It also develops Fexagratinib, which is in Phase II clinical trial for the treatment of urothelial carcinoma; ABSK121, a small molecule FGFR inhibitor that targets both wild-type and mutations of FGFR1-3; ABSK112, an EGFR Exon20ins inhibitor with selectivity over wild-type EGFR and brain-penetration activity; Mavorixafor, an orally bioavailable CXCR4 modulator; and ABSK051, a small molecule CD73 inhibitor for the treatment of various tumor types, such as lung and pancreatic cancer. In addition, the company develops ABSK012, which is in Phase I clinical trial for treatment of soft tissue sarcoma; ABK131, a selective MTA-cooperative and brain-penetrant PRMT5 inhibitor; ABK3376, which is in Phase I clinical trial for the treatment of NSCLC harboring the EGFR-C797S mutation; and ABSK141, an orally bioavailable small-molecule KRAS-G12D inhibitor. Abbisko Cayman Limited was founded in 2016 and is headquartered in Shanghai, the People’s Republic of China.
Name | Age | Since | Title |
---|---|---|---|
Piaoyang Sun | 66 | 2021 | Independent Non-Executive Director |
Yao-Chang Xu | 68 | 2016 | Founder, Chairman of the Board & CEO |
Jing Ji | 54 | 2021 | Chief Medical Officer & Executive Director |
Hongping Yu | 57 | 2016 | Co-Founder, Jt Co Secretary, Senior VP of Chemistry, Chief Scientific Officer & Executive Director |
Hongbin Sun | 50 | 2021 | Independent Non-Executive Director |
Hoi Yam Chui | 57 | 2025 | Independent Non-Executive Director |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review